Scanwell Health

Nurx, Carbon Health and Everlywell have officially halted their mail-order testing-kit services. But at least one startup is still moving to secure an Emergency Use Authorization for its at-home rapid serology diagnostic.

[Since this article was published, the FDA has released an alert warning that it has not yet authorized any COVID-19 home testing kits]

While Scanwell is still expanding its consumer telehealth offering, it's also working to position itself as a broader "diagnostics as a service" partner to the healthcare industry.

The Silicon Valley-based accelerator Y Combinator hosted a demo day with 122 startups, 28 percent healthcare related.